Ending Soon! Save 33% on All Access

Virohan Raises Additional $1.3 Mn From Existing Investors Virohan is planning to utilize these funds to expand to new geographies PAN India

By Prabhjeet Bhatla

Opinions expressed by Entrepreneur contributors are their own.

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Virohan

Healthcare edtech startup Virohan announced on Thursday to have raised an additional $1.3 million in funding from its existing investors - Keiretsu Forum, Priya Shah (Theia Ventures), Better Capital, Vikas Gambhir (Grant Thornton), and Joydeep Battacharya (Bain & Co), before the Series B raise.

Providing industry demand-led training for Allied Healthcare Professionals (AHPs), Virohan is planning to utilize these funds to expand to new geographies PAN India. The startup is also planning to use new funds to develop newer training programs, content in vernacular languages and develop their technological forefront. The additional funds bring Virohan's total funding to $4.3 million since its launch, including a series A round announced in May 2021 that saw participation from Rebright Partners.

"We are thrilled that our investors and the youth of our country believe in, and support the massive healthcare training need. Their decision of the investors to re-invest gives us a further vote of confidence on our goal to train over 2,50,000 youth by 2025," said Kunaal Dudeja, chief executive officer and co-founder, Virohan.

Virohan, which currently operates hybrid classrooms at campuses and online training across India in cities including Delhi, Faridabad, Pune, Raipur, Meerut, and Nagpur, and has a number of distinguishing features but most notable are likely its tech-first approach and talent to fix the socio-economic problem so that industry demand and skilled workforce are in perfect equilibrium. The start-up has a technology-driven training platform, which is able to train personnel, both online and in their allied campuses. Its end-to-end proprietary "technology skill stack' enables job prediction, aggregates training providers, and standardizes processes across the student journey from mobilization to training content to placements, the platform said.

"We are excited to back the Virohan team on their transformative vision to train and empower India's youth in seeking allied healthcare employment in top hospitals and clinics in the country through cutting-edge technology and blended learning tools," added Priya Shah, general partner, Theia Capital.

The company aims to scale its current omnichannel training platform infrastructure and develop new features to further increase learning outcomes for students and facilitate growth over its expanding footprint with this bridge round.

The company is also in talks to raise $7-$10 million in Series B later this year.

Prabhjeet Bhatla

Former Staff

Thought Leaders

Need More Confidence? These 10 Bestselling Books Will Help Improve Your Self-Esteem

Self-esteem can be hard to come by and even harder to maintain. To give yourself a boost, try these authors' words of wisdom.

News and Trends

Navigating the Boom: How Investors Are 'AI-ing' Big in India

While the startup ecosystem tries to leave the funding winter behind, the AI startups and investors are having a pleasant time

News and Trends

Collective Artists Network Secures Investment from Nikhil Kamath

The investment is a secondary transaction, that is poised to open the road to a '5X' return, thanks to a strategic exit for InMobi's Glance, which had an investment in Collective dating back to 2021.

Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.

News and Trends

IVY Growth Launches INR 250 Crore Sector-agnostic VC Fund 'Arigato Capital'

It will look to back agritech, cleantech, generative AI, fintech, consumer brands, and software-as-a-service (SaaS) companies

Science & Technology

How AI and Data Are Revolutionizing the Pharmaceutical Industry

Despite their main products being drugs, pharma companies are driven by the power of data and AI, which helps them prove their value in treating and eradicating diseases.